Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The latest news, stories and exciting findings from across the Oxford cancer research community

University's RadCam library highlighted in yellow

National clinical study launched to test new technologies for detecting liver cancer

The SELINA study will recruit patients with early liver cancers as part of the DeLIVER programme aiming to detect liver cancer earlier.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

Early detection innovation award for Oxford researchers

Professor Julia Hippisley-Cox and Dr Tingting Zhu win funding for their collaborative project on novel test technologies for patient triage in primary care.

Dairy products linked to increased risk of cancer

The first major study to investigate dairy consumption and cancer risk in Chinese adults found that greater intake was associated with higher risks of liver cancer and female breast cancer.

Greater adiposity linked to increased risk of fatal prostate cancer

A new Oxford study finds that greater body fat (adiposity) may increase the risk of dying from prostate cancer by up to 10%.

12 new Development Fund awardees

The awardees from the 2021 round of the CRUK Oxford Centre Development fund have been announced. Read about what research they will be undertaking.

Predicting early recurrence of pancreatic cancer

Dr Daniel Hughes and colleagues identify NUDT15 as a potential biomarker for pancreatic cancer recurrence following surgery.

Genetic testing could reduce adverse effects and hospital costs of a widely used chemotherapy

Testing for DPYD gene variants could be used to mitigate the side-effects of fluoropyrimidine-based chemotherapy

Oxford researchers at AACR 2022

Several Oxford Cancer researchers present at the American Association for Cancer Research (AACR) Annual Meeting.

Automated assessment of pathology image quality

The new Oxford-developed artificial intelligence tool PathProfiler automates the quality control of large retrospective pathology image datasets to increase their usability in downstream research.

Oxford spin-out Optellum attains CE marking for its early lung cancer diagnosis AI technology

Optellum Virtual Nodule Clinic, including its proprietary artificial intelligence lung cancer prediction solution, has achieved CE certification under the European Union’s Medical Device Regulation.

Funding to develop a new device for breast cancer detection

Professor Jason Davis has been awarded a Cancer Research UK Early Detection and Diagnosis Primer Award to develop a single-step, ultra-sensitive device for detecting breast cancer cells in the blood.

Blood tests provide no additional information to FIT alone when prioritising patients for colorectal cancer referral

Faecal immunochemical testing (FIT) alone leads to the identification of the same number of patients with colorectal cancer as more complicated approaches that combine the FIT result with the results of commonly used blood tests.

Adiposity in early life, but not adulthood, may protect against breast cancer

New data from the Million Women Study indicates that adiposity at different life stages is likely to affect the risk of postmenopausal breast cancer through distinct mechanisms.

UK-first cancer operation in Oxford

A UK-first operation that replaced the sternum of a cancer patient using the chest wall of a deceased donor has been carried out at Oxford University Hospitals NHS Foundation Trust (OUH).

New study finds lower risks of cancer for vegetarians, pescatarians and low meat-eaters

Results from a large-scale analysis show that following a vegetarian or pescatarian (fish-eating) diet could significantly reduce the risk of developing cancer – but even limiting red and processed meat to five meals a week or less may also have a benefit.

First major UK prospective study for liver cancer underway

The Pearl clinical study will recruit 3000 patients with high-risk conditions for liver cancer with the aim of detecting liver cancer earlier as part of the Cancer Research UK-funded DeLIVER programme.

DNA link could unlock mystery of cancer patients ‘wasting away’

New research by Oxford researchers into sudden weight loss finds a possible cause of cachexia (sudden weight loss & muscle wasting) in cancer patients and Cockayne syndrome in children.

New study shows MRI-guided radiotherapy could double survival rates for people with inoperable pancreatic cancer

A study in partnership with GenesisCare has found high dose ablative radiotherapy doubles the chance of living at least two years after diagnosis.

How Oxford has shaped cancer science

As part of World Cancer Day 2022 we are diving into 10 of Oxford’s most impactful historical and modern contributions to the field of cancer science and treatment. Read more about what Oxford researchers have done to shape this ever-important area of medical science.

Load More